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SUMMARY 
1. In the rat, the LH-dependent ovarian progesterone rise mediates everal 
actions of the primary surge of LH on the ovary. This experiment was aimed at 
elucidating the effects of the antiprogestagen RU486 on the LH-dependent 
decrease in both the serum concentrations and the ovarian content of inhibin. 
2. All rats in this experiment were treated with an antagonist of LHRH 
(1 mg/200/.d saline at 0800 h in proestrus) to supress the endogenous release of 
LH. One group of rats received 32/xg LH/250/M saline at 1200 h in proestrus. 
Other group was given 4 mg RU486/200/zl oil at 0800 h in proestrus. The third 
group was injected with both RU486 and LH. Rats from the control group were 
injected with 250/zl saline and 200/zl oil. Animals were decapitated at 1700 h in 
proestrus and trunk blood and ovaries collected to determine the serum 
concentrations of LH, FSH, progesterone, 17B-estradiol and inhibin as well as the 
ovarian content of inhibin. 
3. The ovulatory dose of LH in LHRHa-treated rats decreased both the 
serum concentrations and the ovarian content of inhibin and increased the serum 
concentrations of FSH. The administration f RU486 blocked the effect of LH on 
the serum concentrations of inhibin but not that on the ovarian content of 
inhibin. 
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4. Since the antiprogestagen RU486 blocked the effect of LH on the serum 
concentrations of inhibin, we conclude that ovarian progesterone, besides 
mediating the effects of the primary LH surge on the ovulatory process and 
luteinization, participates in the LH-dependent drop in the serum concentrations 
of inhibin in proestrous afternoon. 
INTRODUCTION 
In the cyclic rat, the maximal release of gonadotropins (primary surge of LH and 
FSH) is in the afternoon of proestrus shortly before ovulation. While the 
concentrations of LH fall in the last hours of proestrus, the secretion of FSH 
remains high during the first hours of estrus (secondary surge of FSH) and reachs 
pre-surge values at noon in estrus (Freeman 1981). The control of the secondary 
surge of FSH, which is implicated in the recruitment of a new set of growing 
follicles (Greenwald and Terranova 1988), is not completely known. The 
preovulatory surge of gonadotropins i completely coupled to the LHRH 
secretion (Sarkar et aL, 1976), while the release of FSH during early estrus is 
independent of LHRH (Hasegawa et al., 1981; S~inchez-Criado et al., 1994). It is 
well established, however, that the secondary surge of FSH depends on both the 
preovulatory release of LH (Schwartz and Talley 1978) and the LH-dependent 
drop in the serum concentrations of inhibin (Shander et aL, 1980; Rivier et aL, 
1989). 
The administration of the antiprogesterone and antiglucocorticoid RU486 
blunts the primary surge of LH and FSH and blocks the secondary surge of FSH 
(S~inchez-Criado et al., 1992a; Knox and Schwartz 1992). Moreover, the injection 
of an ovulatory dose of LH does not restore the secondary surge of FSH in rats 
treated with RU486 (Knox et aL, 1993). These data suggest hat another factor, 
which is blocked by RU486, is necessary, together with the drop in the serum 
concentrations of inhibin, to evoke the secondary surge of FSH. Recently, we 
have demonstrated that the secondary surge of FSH during early estrus is evoked 
by the combined effects of the primary surge of LH and the LH-independent rise 
of serum corticosterone in proestrus afternoon (T6bar et aL, 1995a). 
It is known that the LHRH-dependent primary surge of LH induces 
progesterone receptors, luteinization and secretion of progesterone by the 
preovulatory follicles, resulting in a rise in the serum concentrations of proges- 
terone (Natraj and Richards 1993; Uchida et al., 1969). In addition, there are 
evidences that ovarian progesterone mediates the effects of the primary surge of 
LH on the ovulatory events and luteinization (Iwamasa et aL, 1992; Tanaka et al., 
1993; Natraj and Richards 1993). Besides, a preliminary observation from our 
laboratory showed that the administration of RU486 in proestrus tends to 
prevent he LH-dependent drop in the serum concentrations of inhibin (S~nchez- 
Criado et aL, 1993b). 
Overall, these data suggest hat progesterone, through a local inhibitory 
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effect, could mediate the action of the primary surge of LH on the serum 
concentrations of inhibin. The present work was carried out to investigate the 
effect of RU486 on the serum concentrations and on the ovarian content of 
inhibin in the presence or in the absence of the preovulatory surge of LH. 
METHODS 
Animals 
Adult female Wistar rats weighing 180-220g were used. The rats were 
housed (5 per cage) under standard light conditions (lights on from 0500 to 
1900 h) and temperature (20-23°C) with water and food provided "ad libitum". 
Vaginal smears were examined aily. Only rats exhibiting at least two consecutive 
4-day estrous cycles were used. 
Treatments 
Antiprogestagen RU486 (Mifepristone, 11 B-(4-dimethylaminophenyl)-17 
B-hydroxy-17 a-(1-propinyl)-estra-4,9-diene-3-one) was donated by Dr R. Dera- 
edt (Roussel-Uclaf, Romainville, France). This compound has a high affinity for 
progesterone and glucocorticoid receptors (Philibert et al., 1985; van der Schoot et 
al., 1989). Rats were injected (s.c.) with 4 mg/200/zl oil at 0800 h in proestrus. 
Control injections consisted of 200/zl oil. 
The LHRH antagonist (LHRHa) used was ORG.30276 (Ac-D-p-C1-Phe-D- 
p-CI-Phe-D-Trp-Ser-Tyr-D-Arg-Leu-Arg-Pro-D-AIa-NH2.CH3.COOH) (van den 
Dungen et al., 1989) Organon international B.V., Oss, The Netherlands. 
Immediately before use the peptide was dissolved in saline and rats were injected 
(s.c.) with 1 mg/200/zl saline at 0800 h in proestrus. This dosage causes maximal 
suppression of endogenous LH secretion (S~inchez-Criado et al., 1993a). 
Ovine LH (oLH) NIDDK oLH-26 was injected (i.v.) under ether anesthesia 
at 1200 h in proestrus at a dosage of 32/xg/250/zl saline. This LH preparation 
contained less than 0.5% contamination of FSH. Control injections consisted of 
250/~1 saline. 
Experimental Groups 
All the rats were treated with the LHRHa (1 mg/200/zl saline) at 0800 h in 
proestrus. Animals were divided in four groups (n = 7-9) and they were treated 
in proestrus as follows: in the first group, rats were injected with vehicles (200/~1 
oil at 0800 h and 250 ~1 saline at 1200 h); in the second group, rats were given 
injections of RU486 (4 mg/200 ~1 oil at 0800 h) and of saline; in the third group, 
rats were given oil and an ovulatory dose of LH (32/~g/250/zl saline at 1200 h); 
and, in the fourth group, rats were injected with RU486 and LH. All rats were 
decapitated at 1700 h in proestrus and trunk blood and ovaries were collected. 
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Blood was centrifuged for 20 minutes at 2000 x g and the serum was stored frozen 
until the radioimmunoassays were run. The ovaries were handIy homogenated 
(2ml medium 199/ovary) and centrifuged for 1 h at 71000×g and the super- 
natants were stored frozen until the radioimmunoassay was run. 
Radioimmunoassay of Gonadotropins 
Serum concentrations of LH and FSH were measured in duplicate in 50 and 
25 ~1 samples, respectively, using double-antibody RIA methods with the RIA 
kits supplied by NIH (Bethesda, MD) and following the microassay method 
described previously (S~inchez-Criado et al., 1993a). Rat LH-I-9 and FSH-I-8 
were labeled with 1251 by the chloramine T method (Greenwood et al., 1963). LH 
and FSH concentrations were expressed as ng/ml of serum of the reference 
preparation LH-rat-RP-3 and FSH-rat-RP-2, respectively. All samples were run 
in the same assay. The intra-assay coeffÉcients of variation were 7% and 8% for 
LH and FHS, respectively. The sensitivities of the assays were 7.5 and 50 pg/tube 
for LH and FSH, respectively. 
Radioimmunoassay of Steroids 
Serum 1713-estradiol and progesterone concentrations were measured by 
using a commercially obtained kits (Diagnosis Products Corporation, Los 
Angeles, CA). All samples were run in the same assay. The sensitivities of the 
assays were lpg/tube and 10pg/tube for estradiol 1713 and progesterone, 
respectively. The intra-assay coefficients of variation were 6.5% and 6% for 
estradiol 1713 and progesterone, respectively. 
Radioinununoassay of Inhibin 
Serum and ovarian extracts inhibin-like immunoactivity were measured in 
duplicate in 10/zl samples following the method described previously (Robertson 
et al., 1989; S~nchez-Criado et al., 1992b). A bFF preparation with an arbitrary 
potency of 1 U//zg protein was used as the standard. The International Research 
Standard of inhibin (86/690) has a relative specific activity of 60+ 10U//~g 
(mean + S.E.M., n =5) when expressed in units of this bFF standard. All 
samples were run in the same assay. The intra-assay coefficient of variation was 
24.4%. 
Data Evaluation and Statistical Analysis 
Results are given as the mean + SEM. Data were evaluated for statistically 
significant differences using one-way analysis of variance (ANOVA) followed by 
Tukey's Q test. A difference was considered to be statistically significant if 
P < 0.05 in relation of LHRHa-treated rats injected with vehicles. 
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RESULTS 
Serum Concentrations of LH and FSH (Fig. 1) 
The injection of  an ovulatory dose of  LH  to LHRHa- t reated  rats significantly 
increased the serum concentrat ions of FSH at 1700 h in proestrus. This effect o f  
LH  was blocked by the antiprogestagen RU486. The injection of  RU486 alone 
had no effect on the serum concentrations of FSH (Fig. 1B). The administration 
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Fig. L Serum concentrations f LH (A) and FSH (B) at 1700 hin proestrus 
in LHRHa-treated rats (lmg/200g.l) saline s.c.a.t 0800h in proestrus) 
injected in proestrus with: vehicles (200/,tl oil s.c. at 0800 h and 250 9.1 saline 
i.v. at 1200h), RU486 (4mg/200p, l oil s.c. at 0800h) and/or LH 
(32 9,g/250 9,l saline i.v. at 1200h). Values are mean +SEM (7-9 rats). (**) 
P < 0.01 vs LHRHa-treated rats injected with vehicles (One way ANOVA and 
Tukey's test). 
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of RU486 and/or  an ovulatory dose of LH to LHRHa- t reated  rats induced an 
increase in serum concentrat ions of LH at 1700 h in proestrus (Fig. 1A). 
Serum Concentrations of Progesterone and 17B-Estradiol (Fig. 2) 
The ovulatory dose of LH increased serum concentrat ions of progesterone 
at 1700h in proestrus in LHRHa- t reated rats. The administrat ion of RU486 had 
no effect on the serum concentrat ions of progesterone ither in LH- or 
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Fig. 2. Serum concentrations of 17B-estradiol (A) and progesterone (B) at 
1700 h in proestrus in LH RHa-treated rats (1 mg/200/,tl saline s.c. at 0800 h in 
proestrus) injected in proestrus with: vehicles (200/,tl oil s.c. at 0800h and 
250/xl saline i.v. at 1200 h), RU486 (4 mg/200/.tl oil s.c. at 0800 h) and/or LH 
(32 ~g/250 ~l saline i.v. at 1200 h). Values are mean + SEM (7-9 rats). (**) 
P < 0.01 vs LHRHa-treated rats injected with vehicles (One way ANOVA and 
Tukey's test). 
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vehicle-injected rats (Fig. 2B). The serum concentrations of 17B-estradiol at 
1700 h in proestrus were not different among groups of LHRHa-treated rats (Fig. 
2A). 
Ovarian Content and Serum Concentrations of Inhibin (Fig. 3) 
The ovulatory dose of LH in LHRHa-treated rats decreased the ovarian 
content (Fig. 3A) and the serum concentrations of inhibin (Fig. 3B) at 1700 h in 
proestrus. The administration f RU486 blocked the ffect of LH on the serum 
concentrations of inhibin (Fig. 3B) but not on the ovarian content of inhibin (Fig. 
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Fig. 3. Ovarian content of inhibin (A) and serum concentrations of inhibin 
(B) at 1700h in proestrus in LHRHa-treated rats (! mg/200 ~I saline s.c. at 
0800 h in proestrus) injected in proestrus with: vehicles (200 ~1 oil s.c. at 
0800 h and 250 ~1 saline i.v. at 1200 h), RU486 (4 mg/200 ~,1 oil s,c. at 0800 h) 
and/or LH (32 ~g/250 p.1 saline i.v. at 1200h). Values are mean ± SEM (7-9 
rats). (*) P<0.05 and (**) P<0.01 vs LHRHa-treated rats injected with 
vehicles (One way ANOVA and Tukey's test). 
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3A). The injection of RU486 alone did not affect the ovarian content of inhibin 
(Fig. 3A) but induced a decrease in the serum concentrations of inhibin (Fig. 3B). 
DISCUSSION 
The effects of several maneuvers and treatments in proestrus on the secretion 
of FSH in estrus in the cyclic rat are shown in Table I. The abolition of the 
LHRH secretion through the anterior deafferentation of the medium basal 
hypothalamus (Rush et al., 1980) or the blockade of its actions through the 
administration of an antiserum anti-LHRH (Blake and Kelch 1981) in the 
Table I. Effect of Different Maneuvers on the Day of Proestrus on the Secretion of FSH at Early 
Estrus in the Cyclic Rat" 
Reference Treatment Secondary surge of FSH 
Ashiru & Blake 1978 Pb in the early afternoon of proestrus Abolished 
Pb in the evening of proestrus Unaffected 
Pb and LHRH in the afternoon of Restored 
proestrus 
Pb and LH or FSH in the afternoon of 
proestrus 
Anterior deafferentation f MBH in the 
early afternoon of proestrus 
Anterior deafferentation f MBH in the 
evening of proestrus 
LHRH-AS in the early afternoon of 
proestrus 
LHRH-AS in the evening of proestrus 
pFF in the evening of proestrus 
Epostane in the morning of proestrus 
Trilostane in the morning of proestrus 
RU486 from metestrus to proestrus 
RU486 in the morning proestrus 
RU486 and LH in the afternoon of 
proestrus 
RU486 and AIS in the afternoon of 
proestrus 
LHRHa in the evening of proestrus 
LHRHa in the morning of proestrus 
LHRHa and LH in the afternoon of 
proestrus 
APS in the afternoon of proestrus 
ADX in the morning of proestrus 
LHRHa and P in the afternoon of 
proestrus 
LHRHa and AIS in the afternoon of 
proestrus 
LHRHa and P + AIS in the afternoon of 
proestrus 
OVX in the morning of proestrus 
OVX and P in the afternoon of proestrus 
Ashiru&Blake 1979 
Rush et aL 1980 
Restored 
Abolished 
Unaffected 
Blake & Kelch 1981 Abolished 
Unaffected 
Elias et al. 1982 Abolished 
DePaolo 1988 Abolished 
Mahesh & Brann 1992 Abolished 
S~inchez-Criado et aL 1992 Abolished 
Knox & Schwartx 1992 Abolished 
Knox et al. 1993 Abolished 
Sfinchez-Criado et al. 1994 
T~bar et al. 1995a 
T~bar et al. 1995b 
Abolished 
Unaffected 
Abolished 
Restored 
Unaffected 
Decreased 
Partially restored 
Partially restored 
Restored 
Unaffected 
Unaffected 
° Pb: Phenobarbital; MBH: medium basal hypothalamus; LHRH-AS: anti-LHRH serum; pFF: procine 
follicular fluid; RU486: antiprogestagen; AIS: anti-inhibin serum; LHRHa: LHRH antagonist; APS: 
anti-progesterone serum; ADX: adrenalectomy; P: progesterone; OVX: ovariectomy. 
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afternoon but not in the evening of proestrus, prevents the rise in FSH levels in 
the early estrus. Ashiru and Blake (1978) demonstrated that the blockade of the 
primary surge of LH by the administration of phenobarbital in the early 
afternoon but not in the evening of proestrus, abolishes the secondary surge of 
FSH in estrus. When phenobarbital-treated ratsare injected with LHRH (Ashiru 
and Blake 1978) or with LH or FSH (Ashiru and Blake 1979) in the afternoon of 
proestrus, the secretion of FSH in estrus is restored. The secondary surge of FSH 
is not affected by the administration of an antagonist of LHRH (LHRHa) in the 
late proestrus (S~chez-Criado et al., 1994). The treatment with the LHRHa in 
the morning of proestrus induces an abolition of the secondary surge of FSH 
which is restored when LHRHa-treated rats are injected with LH (Trbar et al., 
1995a). All these data clearly demonstrate hat the secretion of FSH in the first 
hours of estrus does not depend on the LHRH secretion in this period but it does 
on the primary surge of gonadotropins. Since the administration of porcine 
follicular fluid in the evening of proestrus blocks the secondary surge of FSH 
(Elias et al., 1982), it is concluded that the secretion of FSH in the early estrus 
depends on the preovulatory LH surge-dependent fall in ovarian inhibin levels 
(Shander et al., 1980). 
The administration of the antiprogesterone RU486 from metestrus to 
proestrus (S~nchez-Criado et al., 1992b) or in the morning of proestrus (Knox 
and Schwartz 1992) blunts the primary surge of gonadotropins and abolishes the 
secondary surge of FSH. When RU486-treated rats are injected with an ovulatory 
dose of LH or with an anti-inhibin serum (AIS) they do not display the secondary 
surge of FSH (Knox et al., 1993). These findings indicate that the secondary surge 
of FSH does not depend on the primary surge of LH itself but on its effects at 
ovarian level and that RU486 could affect he secretion of FSH in estrus through 
antagonizing the action of one or more factors which are necessary to evoke it. 
Since RU486 has also antiglucocorticoid activity, the secretion of corticosterone 
in the afternoon of proestrus could be responsible for the secretion of the 
secondary surge of FSH. In fact, the complete removal of corticosterone from the 
circulation by adrenalectomy (ADX) in the morning of proestrus decreases the 
levels of FSH in the early estrus (Tdbar ¢t al., 1995a). It should be noted that 
ADX decreases but it does not abolish the secondary surge of FSH (Trbar et al., 
1995a). Therefore, another factor blocked by RU486, probably progesterone, 
also could play a role in the regulation of the secretion of FSH in estrus. This 
idea is in agreement with the finding that the administration of the progesterone 
synthesis inhibitors Epostane (DePaolo 1988) or Trilostane (Mahesh and Brann 
1992) to cyclic rats in the morning of proestrus induces an abolition of the 
secretion of FSH in estrus. Besides, we have showed that in LHRHa-treated rats 
the injection of 4 mg of progesterone or an AIS in the afternoon of proestrus 
partially restores, while the combined treatment with progesterone and AIS 
completely restablishes the secondary surge of FSH (Trbar et al., 1995b). These 
results lead us to consider that the LH-dependent secretion of progesterone in 
proestrous afternoon (Uchida et al., 1969) could stimulate the secretion of FSH 
during early estrus either directly at the pituitary level or indirectly through 
inhibitory effects on inhibin production. The first possibility is doubtful since the 
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injection of progesterone in the afternoon of proestrus to OVX-rats does not 
modify the serum concentrations of FSH in estrus (TEbar et al., 1995b). The 
second possibility seems to be more suitable. This is because a) granulosa cells in 
ovarian follicles, which are the main source of inhibin in the female rat (Erickson 
and Hsueh, 1978), have progesterone receptors (Schreiber and Erickson, 1979), 
b) RU486 readily crosses the blood-follicle barrier (Baulieu, 1989) and binds to 
granulosa cells progesterone r ceptors (Schreiber et aL, 1983) and c) progesterone 
added to granulosa cells culture decreases inhibin production (Franchimont et al., 
1981). Moreover, inhibin production by granulosa cells in culture decreases when 
these cells become luteinized (Franchimont 1987) and RU486 prevents luteiniza- 
tion and progesterone production by preovulatory follicles incubated with LH 
(Natraj and Richards 1993). Accordingly, the explanation for the full effect of the 
combined treatment of progesterone and AIS on the secretion of FSH at early 
estrus could be the existence of an additive effect between the ability of AIS to 
neutralize the biological activity of serum inhibin and the reported inhibitory 
effect of progesterone on inhibin production. Ovariectomy (OVX) in the morning 
of proestrus, which completely eliminates progesterone and inhibin from the 
circulation, does not affect the secondary surge of FSH (Tdbar et al., 1995b). This 
demonstrates that ovarian progesterone is not necessary itself to simulate the 
secretion of FSH in estrus and supports the hypothesis of an inhibitory effect of 
progesterone on the secretion of inhibin. The fact that the progesterone-anti- 
progesterone immune complexes do not cross the blood-follicle barrier and, 
therefore, they do not antagonize the local effect of progesterone on inhibin 
secretion could explain the lack of effect of an anti-progesterone s rum on the 
secondary surge of FSH (TEbar et al., 1995a). The discrepancies with previous 
data (Knox et al., 1993) which report that the administration of 2.5 mg of 
progesterone in the afternoon of proestrus to LHRHa-injected rats does not 
increase the secretion of FSH at 0800 h in estrus are attributable to differences in 
the dose of progesterone and in the strength of the AIS used, as well as to the 
time of blood collection. 
The results presented in this paper show that the administration of ovulatory 
dose of LH to LHRHa-treated rats increased the secretion of ovarian proges- 
terone (Fig. 2B). In this endocrine milieu, which was characterized by elevated 
progesterone l vels, there was a fall in both the serum levels and the ovarian 
content of inhibin (Fig. 3) and the secondary surge of FSH was restored (Fig. 1B). 
Both the decrease in inhibin synthesis and the fall in inhibin secretion depend on 
the preovulatory LH surge and they are separate phenomena (Hasegawa et al., 
1989). The effect of the ovulatory dose of LH on the serum concentrations of 
progesterone was not modified by the injection of RU486 (Fig. 2B). The 
administration of RU486 and LH to LHRHa-injected rats decreased the ovarian 
content and did not change the serum levels of inhibin with respect to 
LHRHa-treated rats (Fig. 3). All these results together could be interpreted as 
that ovarian progesterone mediates the inhibitory effect of LH on inhibin 
secretion but not that of LH on inhibin synthesis. It should be noted that RU486 
alone negatively affected the serum levels of inhibin in LHRHa-treated rats (Fig. 
3B) while it did not modify the ovarian content of inhibin (Fig. 3A). RU486 has 
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been reported to act as partial agonist in some tissues and under certain 
conditions (Jordan 1984) and to have agonistic activity in the endometrium and 
pituitary in the absence of progesterone (Gravanis et aL, 1985). Thus. a possible 
explanation for this effect could be that RU486 has the same inhibitory effect 
than progesterone on the secretion of inhibin in the absence of the preovulatory 
surge of LH and, in consequence, of the progesterone rise. In this group of 
animals with low inhibin serum levels, the secondary FSH surge was prevented 
because the corticosterone actions were blocked by the injection of RU486 (Fig 
1B). 
In summary, the data presented in this paper demonstrate that the 
antiprogestagen RU486 blocks the inhibitory action of the preovulatory surge of 
LH on the secretion but not on the ovarian synthesis of inhibin. There are data 
reporting that at 0600 h in estrus the serum concentrations of inhibin are basal in 
rats injected with lower doses (2-6 mg/kg) of RU486 (Knox and Schwartz 1992: 
Knox et aL, 1993). Therefore, the antiprogestagen RU486 would delay, rather 
than prevent, the LH-dependent drop in the serum concentrations of inhibin in 
the afternoon of proestrus. 
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